oral glp-1 medications approved BREAKING: The FDA has the first pill for obesity, marking a major milestone in the weight-loss drug market and a potential inflection point for treatment access. The daily pill Oral GLP-1 Medication Helps Patients

A different non-insulin injectable diabetes medication Victoza (liraglutide) was approved in 2010, but in 2013, the FDA issued a warning to consumers of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas. And this first warning isnt an anomaly

Plasma glucagon was also measured in this study

#EpsilonHealthcare #MedicalDevices #DiagnosticEquipment #PreventiveHealthcare #HealthScreening #EarlyDetection #HealthcareInnovation #MedicalTechnology #PatientCare #HealthcareTechnology To view or add a comment, sign in Her A1C looked controlled. Her kidneys failed anyway, even though her diabetes was controlled

GLP-1 agonists: Who do they work for

Amylin as a future obesity treatment

Compounded drugs are not approved by the FDA and are not required to undergo the same safety and effectiveness testing as brand-name medications